December 18, 2008 - The addition of an apparent diffusion coefficient (ADC) map to T2-weighted images can improve the diagnostic performance of MR imaging in prostate cancer detection.

The study’s objective was to retrospectively assess the incremental value of an ADC map combined with T2-weighted magnetic resonance (MR) images compared with T2-weighted images alone for prostate cancer detection by using a pathologic map as the reference standard.

The study included 52 patients, mean age, 65 years, who underwent endorectal MR imaging and step-section histologic examination. Three readers with varying experience levels reviewed T2-weighted images alone, the ADC map alone, and T2weighted images and ADC maps. The prostate was divided into 12 segments. The probability of prostate cancer in each segment on MR images was recorded with a fivepoint scale. Areas under the receiver operating characteristic curve (AUCs) were compared by using the Z test; sensitivity and specificity were determined with the Z test after adjusting for data clustering.

AUC of T2-weighted and ADC data was greater than that of T2weighted images for all readers in all comparisons. AUC of T2-weighted and ADC data was greater for readers 1 and 2 than for reader 3. Sensitivity of T2weighted and ADC data (reader 1, 88 percent; reader 2, 81 percent; and reader 3, 78 percent) was greater than that of T2-weighted images (reader 1, 74 percent; reader 2, 67 percent; reader 3, 67 percent) for all readers (P .01 for reader 1; P .02 for readers 2 and 3). Specificity of T2-weighted and ADC data was greater than that of T2-weighted images for reader 1 (88 percent vs 79 percent, P .03) and reader 2 (89 percent versus 77 percent, P .001).

The addition of an ADC map to T2-weighted images can improve the diagnostic performance of MR imaging in prostate cancer detection.

Source: RSNA 2008 from the Department of Radiology, Asan Medical Center, University of Ulsan, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, South Korea.

For more information: www.rsna.org


Related Content

News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group, led by authors at the University of Toronto, have developed an approach for ...

Time April 23, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
Subscribe Now